San Francisco Bay Area
Accomplished executive leader and seasoned drug development professional with more than two decades of biopharmaceutical industry experience in global organizational leadership roles in US & Europe. Proven expertise in leading and scaling global, multi-disciplinary organizations successfully delivering innovative scientific approaches and end-to-end nonclinical and translational drug development strategies for biopharmaceuticals, synthetic molecules, complex therapeutic modalities, and medical devices. Recognized for a visionary, strategic enterprise mindset and documented success in pioneering transformative organizational strategies and complex change management initiatives. Inspiring people leader dedicated to cultivating high performing teams and trusted mentor promoting personal growth and career development. Successful track record of advancing innovative therapeutic modalities from discovery through preclinical development and First-in-Human trials, culminating in successful global market authorizations.
Accountability for strategic, scientific and organizational leadership of four major departments with global responsibilities for Nonclinical and Translational Safety Assessment, BioAnalytical Sciences, Clinical Pharmacology, and Preclinical & Translational PKPD.
Head of Nonclinical Safety Assessment spanning Nonclinical Operations, Toxicological Pathology, Toxicology and Occupational Toxicology Functions.
Head of the Regulatory Toxicology and Product Quality/ Occupational Toxicology groups.
Oversight of bio-superior biopharmaceuticals portfolio, cross-functional translational sciences team lead and global toxicology project lead.
Head of Nonclinical Safety, Nonclinical DMPK, the GLP-certified Biological Analytics, and Laboratory Animal Sciences.
Group leader Toxicology and Safety Pharmacology.